A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

ConditionOcular Tumor
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Eligibility criteria

Qualifiers

Age ≥18 years.

At least 1 eye that has an intraocular or ocular surface tumor.

The presence of a natural crystalline lens or intraocular lens.

Pupils that can dilate up to at least 3 mm in the study eyes.

Disqualifiers

Does not meet ALL of the above conditions

Trial design

Treatments tested in this trial

  • Intalight Dream OCT
  • Heidelberg Spectralis OCT

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators